Tag: Lisaftoclax

Ascentage Pharma Declares a New Drug Software for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Really helpful Precedence Evaluation Designation by CDE of China NMPA

ROCKVILLE, Md. and SUZHOU, China, Nov. 17, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a worldwide biopharmaceutical firm engaged in discovering,…

Business